SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 79 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,775 | +28.0% | 16,432 | 0.0% | 0.00% | – |
| Q1 2023 | $12,324 | +103.5% | 16,432 | 0.0% | 0.00% | – |
| Q4 2022 | $6,055 | -13.5% | 16,432 | -0.6% | 0.00% | – |
| Q3 2022 | $7,000 | -46.2% | 16,531 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -38.1% | 16,531 | 0.0% | 0.00% | – |
| Q1 2022 | $21,000 | 0.0% | 16,531 | 0.0% | 0.00% | – |
| Q4 2021 | $21,000 | -41.7% | 16,531 | -0.0% | 0.00% | – |
| Q3 2021 | $36,000 | -41.9% | 16,532 | 0.0% | 0.00% | – |
| Q2 2021 | $62,000 | +14.8% | 16,532 | 0.0% | 0.00% | – |
| Q1 2021 | $54,000 | -14.3% | 16,532 | -10.8% | 0.00% | – |
| Q4 2020 | $63,000 | -17.1% | 18,531 | 0.0% | 0.00% | – |
| Q3 2020 | $76,000 | -32.7% | 18,531 | -44.7% | 0.00% | – |
| Q2 2020 | $113,000 | +140.4% | 33,531 | +67.4% | 0.00% | – |
| Q1 2020 | $47,000 | -39.0% | 20,031 | -4.8% | 0.00% | – |
| Q4 2019 | $77,000 | +108.1% | 21,031 | +326.4% | 0.00% | – |
| Q2 2017 | $37,000 | +2.8% | 4,932 | -9.9% | 0.00% | – |
| Q1 2017 | $36,000 | +50.0% | 5,473 | 0.0% | 0.00% | – |
| Q4 2016 | $24,000 | -14.3% | 5,473 | -9.3% | 0.00% | – |
| Q3 2016 | $28,000 | -30.0% | 6,032 | -1.6% | 0.00% | – |
| Q2 2016 | $40,000 | +53.8% | 6,132 | +48.4% | 0.00% | – |
| Q1 2016 | $26,000 | +8.3% | 4,132 | +2.5% | 0.00% | – |
| Q4 2015 | $24,000 | 0.0% | 4,032 | 0.0% | 0.00% | – |
| Q3 2015 | $24,000 | 0.0% | 4,032 | 0.0% | 0.00% | – |
| Q1 2015 | $24,000 | +14.3% | 4,032 | +30.1% | 0.00% | – |
| Q4 2014 | $21,000 | 0.0% | 3,100 | +19.2% | 0.00% | – |
| Q3 2014 | $21,000 | +90.9% | 2,600 | +85.7% | 0.00% | – |
| Q2 2014 | $11,000 | +266.7% | 1,400 | +250.0% | 0.00% | – |
| Q1 2014 | $3,000 | -25.0% | 400 | -20.0% | 0.00% | – |
| Q4 2013 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2013 | $4,000 | -20.0% | 500 | -28.6% | 0.00% | – |
| Q2 2013 | $5,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |